Developmental Research Program
Developmental Research Program
批准号:
10716160
负责人:
GERTRAUD MASKARINEC
金额:
$12.05万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-19 至 2026-07-31
关键词:
AddressAreaAwardBehavioralBiologicalCancer BurdenCancer CenterCatchment AreaCharacteristicsClinical TrialsCollaborationsCommunity OutreachCreativenessDataDevelopmentEducationEducational workshopElementsEnsureEquityEthnic OriginEthnic PopulationEvaluationFacultyFosteringFundingFutureGoalsHawaiiHumanInstitutionInterventionInvestigationLeadershipMalignant NeoplasmsMentorsMinority Health ResearchMissionMonitorNational Cancer InstituteOutcomePatient CarePilot ProjectsPopulation HeterogeneityProcessRequest for ApplicationsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsReview CommitteeSeminalStandardizationStrategic PlanningTalentsTherapeuticTranslatingTranslational ResearchUnderrepresented MinorityUniversitiesWorkcancer health disparitycancer riskclinical diagnosticsethnic differenceimprovedinnovationinter-institutionalminority disparityminority healthminority health disparityprogramsracial differenceracial populationsuccesstranslational impact
中文摘要
总结
夏威夷大学癌症中心(UHCC)是唯一一个国家癌症研究所指定的癌症
在夏威夷和太平洋的中心。该中心的使命是通过研究减轻癌症的负担,
社区外展,教育和病人护理,重点是独特的种族,文化和
夏威夷和太平洋的环境特征。为了配合这一使命,
研究计划(DRP)将利用UHCC的独特机会来促进少数民族的健康
研究将提高我们对癌症风险和结果的种族/种族差异的生物学理解
并将我们的发现转化为治疗,行为和诊断临床试验,
应对这些挑战的措施。DRP是P50的核心要素,用于开发新的
少数民族健康的转化研究项目,将培育新的调查,研究
创新和协作。资助的试点项目将为未来的大型项目提供重要的初步数据
研究项目申请并支持其可行性和影响。此外,DRP研究与翻译
如果DRP研究将人类终点纳入其中,
项目目标之一。因此,DRP将成为转化少数民族健康创新的引擎
在UHCC的研究。因此,我们将其活动与P50和P50的领导密切结合起来
UHCC。在这里,我们描述了试点项目的征求、审查、授予和
监测。DRP的目标是确定和资助10个新的研究项目和合作超过5个
年,解决少数民族健康问题在UHCC的集水区。为了实现这一目标,DRP
协调试点资金申请、审查和奖励活动,并确定具有独特机会的领域,
潜在的合作。UHCC准备为理解和减轻
通过战略性少数民族健康和差异研究,在我们多样化的集水区减轻癌症负担。的
DRP将积极利用这些优势,促进创造性的工作,将转化为
治疗、行为和诊断临床试验以及直接影响少数群体健康的干预措施。
这些项目将构成这个少数民族健康SPORE继续成功的基础,并扩大其
通过促进新的研究课题的发展产生影响。
英文摘要
SUMMARY
The University of Hawai`i Cancer Center (UHCC) is the only National Cancer Institute-designated cancer
center in Hawai`i and the Pacific. The Center's mission is to reduce the burden of cancer through research,
community outreach, education and patient care with an emphasis on the unique ethnic, cultural and
environmental characteristics of Hawai`i and the Pacific. In alignment with this mission, the Developmental
Research Program (DRP) will draw upon areas of unique opportunity at UHCC to foster minority health
research that will improve our biological understanding of ethnic/racial differences in cancer risk and outcomes
in our catchment area and translate our findings into therapeutic, behavioral, and diagnostic clinical trials and
interventions that address these challenges. The DRP is a central element of the P50 for developing new
translational research projects in minority health that will nurture new lines of investigation, research
innovation, and collaboration. The funded pilot projects will provide important preliminary data for future large
research project applications and support their feasibility and impact. Also, DRP studies with translational
research potential may become full SPORE projects if the DRP study incorporates a human endpoint within
one of the project aims. Therefore, the DRP will be an engine for innovation in translational minority health
research at UHCC. As such we have integrated its activities closely with the leadership of the P50 and that of
the UHCC. Here we describe the process by which pilot projects will be solicited, reviewed, awarded, and
monitored. The goal of the DRP is to identify and fund 10 new research projects and collaborations over five
years that address minority health issues in UHCC's catchment area. In support of this goal, the DRP
coordinate pilot funding requests, reviews, and award activities and identify areas of unique opportunity and
potential collaborations. UHCC is poised to make seminal contributions to understanding and alleviating the
burden of cancer in our diverse catchment area through strategic minority health and disparities research. The
DRP will proactively take advantage of these advantages to foster creative work that will translate into
therapeutic, behavioral, and diagnostic clinical trials and interventions that directly impact minority health.
These projects will form the basis for the continued success of this minority health SPORE and expand its
impact by fostering the development of new research topics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Career Enhancement Program
-
批准号:10716161
-
项目类别:
-
资助金额:$8.41万
-
财政年份:2023
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Urinary Estrogen Metabolites in a 2-year Soy Trial Among Premenopausal Women
-
批准号:8034695
-
项目类别:
-
资助金额:$6.63万
-
财政年份:2010
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Urinary Estrogen Metabolites in a 2-year Soy Trial Among Premenopausal Women
-
批准号:7896351
-
项目类别:
-
资助金额:$6.84万
-
财政年份:2010
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Research Education Core
-
批准号:10490859
-
项目类别:
-
资助金额:$19.42万
-
财政年份:2009
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Research Education Core
-
批准号:10266803
-
项目类别:
-
资助金额:$19.23万
-
财政年份:2009
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
A pooled analysis of mammographic density and breast cancer risk
-
批准号:7775049
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2009
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Research Education Core
-
批准号:10084116
-
项目类别:
-
资助金额:$17.13万
-
财政年份:2009
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
BREAST DENSITY BY DXA
-
批准号:7960432
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2009
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
A pooled analysis of mammographic density and breast cancer risk
-
批准号:7660546
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2009
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
BREAST DENSITY BY DXA
-
批准号:7725330
-
项目类别:
-
资助金额:$1.78万
-
财政年份:2008
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Inflammatory Markers in a 2-Year Soy Intervention among Premenopausal Women
-
批准号:7491148
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2007
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Nutritional Risk Factors for Type 2 Diabetes in the Multiethnic Cohort
-
批准号:7416795
-
项目类别:
-
资助金额:$20.34万
-
财政年份:2007
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Nutritional Risk Factors for Type 2 Diabetes in the Multiethnic Cohort
-
批准号:7248549
-
项目类别:
-
资助金额:$18.55万
-
财政年份:2007
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Inflammatory Markers in a 2-Year Soy Intervention among Premenopausal Women
-
批准号:7320589
-
项目类别:
-
资助金额:$6.92万
-
财政年份:2007
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Soy Consumption and Breast Tissue Proliferation
-
批准号:6917401
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2005
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Soy Consumption and Breast Tissue Proliferation
-
批准号:7121567
-
项目类别:
-
资助金额:$21.7万
-
财政年份:2005
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
SOY CONSUMPTION AND HORMONAL DEVELOPMENT IN YOUNG GIRLS: A FEASIBILITY STUDY
-
批准号:7169042
-
项目类别:
-
资助金额:$1.83万
-
财政年份:2005
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
SOY CONSUMPTION AND HORMONAL DEVELOPMENT IN YOUNG GIRLS: A FEASIBILITY STUDY
-
批准号:7011579
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2004
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Breast Density, IGF-I, & Prolactin, in Four Populations
-
批准号:6804044
-
项目类别:
-
资助金额:$6.82万
-
财政年份:2003
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
Breast Density, IGF-I, & Prolactin, in Four Populations
-
批准号:6742960
-
项目类别:
-
资助金额:$6.82万
-
财政年份:2003
-
负责人:GERTRAUD MASKARINEC
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: